Meeting Register Page

A New Treatment Option in Obesity Medicine 8:008:00 8:308:30 9:009:00 9:309:30 10:0010:00 10:3010:30 11:0011:00 11:3011:30
Arizona Obesity Organization is hosting a free event:

"A New Treatment Option in Obesity Medicine"

Discuss the indication and use of semaglutide 2.4mg QW


Dr, Danielle Gilliam, PharmD, MPH
Senior Medical Liaison, Obesity, Novo Nordisk

Dr. Danielle Gilliam , PharmD, MPH is a Senior Obesity Medical Liaison (ML) with Novo Nordisk Inc. (NNI) on the West Coast.

She has over a decade of experience in the area of obesity and has completed her Master’s in Public Health - Policy and Administration degree with a concentration in Health Disparities at the University of Illinois-Chicago School of Public Health. She is certified in diabetes education and medical writing and editing.

Dr. Gilliam has a strong commitment to her community. She represents the American Diabetes Association (ADA) as the President of the Community Leadership Board Phoenix Chapter and as a member of the Diversity Committee for the National ADA Chapter.

Jul 15, 2021 06:00 PM in Arizona

* Required information